In Vitro and In Vivo Efficacies of Teicoplanin-Loaded Calcium Sulfate for Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Osteomyelitis
Open Access
- 1 January 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (1) , 170-176
Abstract
The i n vitro and in vivo therapeutic efficacies of teicoplanin-loaded calcium sulfate (TCS; 10% [wt] teicoplanin) were investigated in a rabbit model of chronic methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. The in vitro elution characteristics of teicoplanin from TCS pellets were realized by carrying out an evaluation of the release kinetics, recovery rate, and antibacterial activity of the released teicoplanin. Chronic osteomyelitis was induced by inoculating 10 7 CFU of a MRSA strain into the tibial cavity of rabbits. After 3 weeks, the animals were treated by debridement followed by implantation of TCS pellets in group 1, calcium sulfate (CS) pellets alone in group 2, and intravenous (i.v.) teicoplanin (6 mg/kg of body weight every 12 h for three doses and then every 24 h up to 4 weeks) in group 3. Animals in group 4 were left untreated. After 6 weeks, the efficacy of the osteomyelitis treatment was evaluated by hematological, radiological, microbiological, and histological examinations. In vitro elution studies showed sustained release of teicoplanin at a therapeutic level over a time period of 3 weeks. The released teicoplanin maintained its antibacterial activity. In vivo , the best therapeutic effect was observed in animals treated with TCS pellets, resulting in significantly lower radiological and histological scores, lower positive rates of MRSA culture and bacterial load, and excellent bone regeneration compared with those treated by CS alone or i.v. teicoplanin, without any local or systemic adverse effects. TCS pellets are an effective alternative to i.v. teicoplanin for the treatment of chronic MRSA osteomyelitis, particularly because teicoplanin is delivered locally while the TCS pellets simultaneously promote bone defect repair.Keywords
This publication has 30 references indexed in Scilit:
- Increasing Antibiotic Resistance among Methicillin‐ResistantStaphylococcus aureusStrainsClinical Infectious Diseases, 2008
- Antibiotics for Local Delivery Systems Cause Skeletal Cell Toxicity In VitroClinical Orthopaedics and Related Research, 2007
- Local Antibiotic Delivery with OsteoSet??, DBX??, and Collagraft??Clinical Orthopaedics and Related Research, 2006
- Calcium Sulfate: A ReviewJournal of Long-Term Effects of Medical Implants, 2005
- Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre studyJournal of Antimicrobial Chemotherapy, 2004
- Biodegradable implantable teicoplanin beads for the treatment of bone infectionsInternational Journal of Pharmaceutics, 2002
- Characterization of a rabbit model of staphylococcal osteomyelitisJournal of Orthopaedic Research, 1997
- TeicoplaninDrugs, 1994
- Antibiotic-Impregnated Plaster of Paris BeadsClinical Orthopaedics and Related Research, 1992
- Treatment of bone and soft tissue infections with teicoplaninJournal of Antimicrobial Chemotherapy, 1990